Coya Therapeutics, Inc. (COYA) Tops Q3 EPS by 10c

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q3 EPS of ($0.26), $0.10 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

You May Also Be Interested In

• Raymond James Reiterates Outperform Rating on Southwest (LUV)
• Victoria Secret (VSXY) PT Lowered to $95 at BofA Securities
• CIENA (CIEN) PT Lowered to $525 at Rosenblatt, 'We're buying this dip'